1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
2.3. Market Sizing and Forecast
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.3.3. Market Share Analysis
2.4. Assumptions for the Study
3. Executive Summary
4. Market Insights
4.1. Overview
4.2. Factors Affecting Market Growth
4.2.1. Impact Analysis of Market Dynamics
4.2.1.1. Rising Prevalence of Genetic Diseases and the Incorporation of Genomic Data in Clinical Workflows Driving Market Growth
4.2.1.2. Concerns Over the Security & Privacy of Genomic Data Limiting the Adoption of Genomics Products
4.2.1.3. Rising Adoption of Personalized Medicines and Gene Therapies
4.2.1.4. Commercializing and Scaling Genomic Technologies Remain Major Challenges for Market Stakeholders
4.2.2. Factor Analysis
4.3. Technology Trends
4.4. Genomics Market: Regulatory Analysis
4.4.1. North America
4.4.1.1. U.S.
4.4.1.2. Canada
4.4.2. Europe
4.4.2.1. Shift From Pre-Approval to A Lifecycle Approach
4.4.2.2. Classification Changes
4.4.2.3. Stronger Supervision
4.4.2.4. Clearer Rights and Responsibilities for Economic Operators
4.4.2.5. Traceability/EUDAMED
4.4.2.6. General Safety and Performance Requirements
4.4.2.7. Performance Evaluation and Clinical Evidence
4.4.3. Asia-Pacific
4.4.3.1. China
4.4.3.2. Japan
4.4.3.3. India
4.4.4. Latin America
4.4.5. Middle East & Africa
4.4.6. Guidelines and Regulations for Gene Therapy and Genome Editing
4.5. Pricing Analysis
4.6. Porter's Five Forces Analysis
4.6.1. Bargaining Power of Buyers
4.6.2. Bargaining Power of Suppliers
4.6.3. Threat of Substitutes
4.6.4. Threat of New Entrants
4.6.5. Degree of Competition
5. Genomics Market Assessment—by Offering
5.1. Overview
5.2. Consumables
5.3. Instruments
5.4. Software
5.5. Services
6. Genomics Market Assessment—by Technology
6.1. Overview
6.2. Polymerase Chain Reaction (PCR)
6.3. Sequencing
6.3.1. Next-Generation Sequencing (NGS)
6.3.2. Other Sequencing Technologies
6.4. Nucleic Acid Extraction & Purification
6.5. Microarray
6.6. Other Technologies
7. Genomics Market Assessment—by Application
7.1. Overview
7.2. Diagnostics
7.3. Drug Discovery & Development
7.4. Life Sciences Research
7.4.1. Cancer Research
7.4.2. Stem Cell Research
7.4.3. Other Life Sciences Research
7.5. Other Applications
8. Genomics Market Assessment—by End User
8.1. Overview
8.2. Pharmaceutical & Biotechnology Companies
8.3. Hospitals & Clinics
8.4. Diagnostic Laboratories
8.5. Contract Research Organizations (CROs)
8.6. Academic & Research Institutes
8.7. Other End Users
9. Genomics Market Assessment—by Geography
9.1. Overview
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K.
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest Of Europe
9.4. Asia-Pacific
9.4.1. China
9.4.2. Japan
9.4.3. India
9.4.4. Rest Of Asia-Pacific
9.5. Latin America
9.5.1. Brazil
9.5.2. Mexico
9.5.3. Rest of Latin America
9.6. Middle East & Africa
10. Competition Analysis
10.1. Introduction
10.2. Key Growth Strategies
10.3. Competitive Benchmarking
10.4. Competitive Dashboard
10.4.1. Industry Leaders
10.4.2. Market Differentiators
10.4.3. Vanguards
10.4.4. Emerging Companies
10.5. Market Share Analysis
10.5.1. Thermo Fisher Scientific Inc. (U.S.)
10.5.2. Illumina, Inc. (U.S.)
10.5.3. Qiagen N.V. (Netherlands)
11. Company Profiles (Company Overview, Financial Snapshot, Product Portfolio, and Strategic Developments)
11.1. Thermo Fisher Scientific Inc.
11.2. Illumina, Inc
11.3. Qiagen N.V.
11.4. Danaher Corporation
11.5. Agilent Technologies, Inc.
11.6. Bio-Rad Laboratories, Inc.
11.7. Pacific Biosciences of California, Inc.
11.8. Oxford Nanopore Technologies plc
11.9. Eppendorf SE
11.10. Myriad Genetics, Inc.
11.11. Reevity, Inc. (Formerly PerkinElmer, Inc.)
11.12. BGI Genomics Co.,Ltd.
(Note: SWOT Analysis of Top 5 Companies is Provided)
12. Appendix
12.1. Available Customization
12.2. Related Reports
List of Tables
Table 1 Regulatory Authorities Governing Genomic Products, by Country/Region
Table 2 Guidelines for Gene Therapy and Genome Editing, by Regulatory Body
Table 3 Pricing: Genomics Instruments
Table 4 Pricing: Genomics Consumables
Table 5 Average Selling Prices: Genomics Instruments
Table 6 Average Selling Prices: Genomics Consumables
Table 7 Global Genomics Market, by Offering, 2022–2031 (USD Million)
Table 8 Global Genomics Consumables Market, by Country/Region, 2022–2031 (USD Million)
Table 9 Global Genomics Instruments Market, by Country/Region, 2022–2031 (USD Million)
Table 10 Global Genomics Software Market, by Country/Region, 2022–2031 (USD Million)
Table 11 Global Genomics Services Market, by Country/Region, 2022–2031 (USD Million)
Table 12 Global Genomics Market, by Technology, 2022–2031 (USD Million)
Table 13 Global Genomics Market for Polymerase Chain Reaction, by Country/Region, 2022–2031 (USD Million)
Table 14 Global Genomics Market for Sequencing, by Type, 2022–2031 (USD Million)
Table 15 Global Genomics Market for Sequencing, by Country/Region, 2022–2031 (USD Million)
Table 16 Global Genomics Market for Next-Generation Sequencing, by Country/Region, 2022–2031 (USD Million)
Table 17 Global Genomics Market for Other Sequencing Technologies, by Country/Region, 2022–2031 (USD Million)
Table 18 Global Genomics Market for Nucleic Acid Extraction and Purification, by Country/Region, 2022–2031 (USD Million)
Table 19 Global Genomics Market for Microarrays, by Country/Region, 2022–2031 (USD Million)
Table 20 Global Genomics Market for Other Technologies, by Country/Region, 2022–2031 (USD Million)
Table 21 Global Genomics Market, by Application, 2022–2031 (USD Million)
Table 22 Global Genomics Market for Diagnostics, by Country/Region, 2022–2031 (USD Million)
Table 23 Global Genomics Market for Drug Discovery and Development, by Country/Region, 2022–2031 (USD Million)
Table 24 Global Genomics Market for Life Sciences Research, by Type, 2022–2031 (USD Million)
Table 25 Global Genomics Market for Life Sciences Research, by Country/Region, 2022–2031 (USD Million)
Table 26 Number of New Cancer Cases, by Region, 2020 Vs. 2040 (In Million)
Table 27 Global Genomics Market for Cancer Research, by Country/Region, 2022–2031 (USD Million)
Table 28 Global Genomics Market for Stem Cell Research, by Country/Region, 2022–2031 (USD Million)
Table 29 Global Genomics Market for Other Life Sciences Research, by Country/Region, 2022–2031 (USD Million)
Table 30 Global Genomics Market for Other Applications, by Country/Region, 2022–2031 (USD Million)
Table 31 Global Genomics Market, by End User, 2022–2031 (USD Million)
Table 32 Global Genomics Market for Pharmaceutical & Biotechnology Companies, by Country/Region, 2022–2031 (USD Million)
Table 33 Global Genomics Market for Hospitals & Clinics, by Country/Region, 2022–2031 (USD Million)
Table 34 Global Genomics Market for Diagnostic Laboratories, by Country/Region, 2022–2031 (USD Million)
Table 35 Global Genomics Market for Contract Research Organizations (CROs) by Country/Region, 2022–2031 (USD Million)
Table 36 Global Genomics Market for Academic & Research Institutes, by Country/Region, 2022–2031 (USD Million)
Table 37 Global Genomics Market for Other End Users, by Country/Region, 2022–2031 (USD Million)
Table 38 Global Genomics Market, by Country/Region, 2022–2031 (USD Million)
Table 39 North America: Genomics Market, by Country, 2022–2031 (USD Million)
Table 40 North America: Genomics Market, by Offering, 2022–2031 (USD Million)
Table 41 North America: Genomics Market, by Technology, 2022–2031 (USD Million)
Table 42 North America: Sequencing Market, by Type, 2022–2031 (USD Million)
Table 43 North America: Genomics Market, by Application, 2022–2031 (USD Million)
Table 44 North America: Genomics Market for Life Science Research, by Type, 2022–2031 (USD Million)
Table 45 North America: Genomics Market, by End User, 2022–2031 (USD Million)
Table 46 U.S.: Genomics Market, by Offering, 2022–2031 (USD Million)
Table 47 U.S.: Genomics Market, by Technology, 2022–2031 (USD Million)
Table 48 U.S.: Sequencing Market, by Type, 2022–2031 (USD Million)
Table 49 U.S.: Genomics Market, by Application, 2022–2031 (USD Million)
Table 50 U.S.: Genomics Market for Life Science Research, by Type, 2022–2031 (USD Million)
Table 51 U.S.: Genomics Market, by End User, 2022–2031 (USD Million)
Table 52 Canada: Genomics Market, by Offering, 2022–2031 (USD Million)
Table 53 Canada: Genomics Market, by Technology, 2022–2031 (USD Million)
Table 54 Canada: Sequencing Market, by Type, 2022–2031 (USD Million)
Table 55 Canada: Genomics Market, by Application, 2022–2031 (USD Million)
Table 56 Canada: Genomics Market for Life Science Research, by Type, 2022–2031 (USD Million)
Table 57 Canada: Genomics Market, by End User, 2022–2031 (USD Million)
Table 58 Europe: Genomics Market, by Country/Region, 2022–2031 (USD Million)
Table 59 Europe: Genomics Market, by Offering, 2022–2031 (USD Million)
Table 60 Europe: Genomics Market, by Technology, 2022–2031 (USD Million)
Table 61 Europe: Sequencing Market, by Type, 2022–2031 (USD Million)
Table 62 Europe: Genomics Market, by Application, 2022–2031 (USD Million)
Table 63 Europe: Genomics Market for Life Science Research, by Type, 2022–2031 (USD Million)
Table 64 Europe: Genomics Market, by End User, 2022–2031 (USD Million)
Table 65 Germany: Genomics Market, by Offering, 2022–2031 (USD Million)
Table 66 Germany: Genomics Market, by Technology, 2022–2031 (USD Million)
Table 67 Germany: Sequencing Market, by Type, 2022–2031 (USD Million)
Table 68 Germany: Genomics Market, by Application, 2022–2031 (USD Million)
Table 69 Germany: Genomics Market for Life Science Research, by Type, 2022–2031 (USD Million)
Table 70 Germany: Genomics Market, by End User, 2022–2031 (USD Million)
Table 71 France: Genomics Market, by Offering, 2022–2031 (USD Million)
Table 72 France: Genomics Market, by Technology, 2022–2031 (USD Million)
Table 73 France: Sequencing Market, by Type, 2022–2031 (USD Million)
Table 74 France: Genomics Market, by Application, 2022–2031 (USD Million)
Table 75 France: Genomics Market for Life Science Research, by Type, 2022–2031 (USD Million)
Table 76 France: Genomics Market, by End User, 2022–2031 (USD Million)
Table 77 U.K.: Genomics Market, by Offering, 2022–2031 (USD Million)
Table 78 U.K.: Genomics Market, by Technology, 2022–2031 (USD Million)
Table 79 U.K.: Sequencing Market, by Type, 2022–2031 (USD Million)
Table 80 U.K.: Genomics Market, by Application, 2022–2031 (USD Million)
Table 81 U.K.: Genomics Market for Life Science Research, by Type, 2022–2031 (USD Million)
Table 82 U.K.: Genomics Market, by End User, 2022–2031 (USD Million)
Table 83 Italy: Genomics Market, by Offering, 2022–2031 (USD Million)
Table 84 Italy: Genomics Market, by Technology, 2022–2031 (USD Million)
Table 85 Italy: Sequencing Market, by Type, 2022–2031 (USD Million)
Table 86 Italy: Genomics Market, by Application, 2022–2031 (USD Million)
Table 87 Italy: Genomics Market for Life Science Research, by Type, 2022–2031 (USD Million)
Table 88 Italy: Genomics Market, by End User, 2022–2031 (USD Million)
Table 89 Spain: Genomics Market, by Offering, 2022–2031 (USD Million)
Table 90 Spain: Genomics Market, by Technology, 2022–2031 (USD Million)
Table 91 Spain: Sequencing Market, by Type, 2022–2031 (USD Million)
Table 92 Spain: Genomics Market, by Application, 2022–2031 (USD Million)
Table 93 Spain: Genomics Market for Life Science Research, by Type, 2022–2031 (USD Million)
Table 94 Spain: Genomics Market, by End User, 2022–2031 (USD Million)
Table 95 Rest of Europe: Genomics Market, by Offering, 2022–2031 (USD Million)
Table 96 Rest of Europe: Genomics Market, by Technology, 2022–2031 (USD Million)
Table 97 Rest of Europe: Sequencing Market, by Type, 2022–2031 (USD Million)
Table 98 Rest of Europe: Genomics Market, by Application, 2022–2031 (USD Million)
Table 99 Rest of Europe: Genomics Market for Life Science Research, by Type, 2022–2031 (USD Million)
Table 100 Rest of Europe: Genomics Market, by End User, 2022–2031 (USD Million)
Table 101 Asia-Pacific: Genomics Market, by Country/Region, 2022–2031 (USD Million)
Table 102 Asia-Pacific: Genomics Market, by Offering, 2022–2031 (USD Million)
Table 103 Asia-Pacific: Genomics Market, by Technology, 2022–2031 (USD Million)
Table 104 Asia-Pacific: Sequencing Market, by Type, 2022–2031 (USD Million)
Table 105 Asia-Pacific: Genomics Market, by Application, 2022–2031 (USD Million)
Table 106 Asia-Pacific: Genomics Market for Life Science Research, by Type, 2022–2031 (USD Million)
Table 107 Asia-Pacific: Genomics Market, by End User, 2022–2031 (USD Million)
Table 108 China: Genomics Market, by Offering, 2022–2031 (USD Million)
Table 109 China: Genomics Market, by Technology, 2022–2031 (USD Million)
Table 110 China: Sequencing Market, by Type, 2022–2031 (USD Million)
Table 111 China: Genomics Market, by Application, 2022–2031 (USD Million)
Table 112 China: Genomics Market for Life Science Research, by Type, 2022–2031 (USD Million)
Table 113 China: Genomics Market, by End User, 2022–2031 (USD Million)
Table 114 Japan: Genomics Market, by Offering, 2022–2031 (USD Million)
Table 115 Japan: Genomics Market, by Technology, 2022–2031 (USD Million)
Table 116 Japan: Sequencing Market, by Type, 2022–2031 (USD Million)
Table 117 Japan: Genomics Market, by Application, 2022–2031 (USD Million)
Table 118 Japan: Genomics Market for Life Science Research, by Type, 2022–2031 (USD Million)
Table 119 Japan: Genomics Market, by End User, 2022–2031 (USD Million)
Table 120 India: Genomics Market, by Offering, 2022–2031 (USD Million)
Table 121 India: Genomics Market, by Technology, 2022–2031 (USD Million)
Table 122 India: Sequencing Market, by Type, 2022–2031 (USD Million)
Table 123 India: Genomics Market, by Application, 2022–2031 (USD Million)
Table 124 India: Genomics Market for Life Science Research, by Type, 2022–2031 (USD Million)
Table 125 India: Genomics Market, by End User, 2022–2031 (USD Million)
Table 126 Rest of Asia-Pacific: Genomics Market, by Offering, 2022–2031 (USD Million)
Table 127 Rest of Asia-Pacific: Genomics Market, by Technology, 2022–2031 (USD Million)
Table 128 Rest of Asia-Pacific: Sequencing Market, by Type, 2022–2031 (USD Million)
Table 129 Rest of Asia-Pacific: Genomics Market, by Application, 2022–2031 (USD Million)
Table 130 Rest of Asia-Pacific: Genomics Market for Life Science Research, by Type, 2022–2031 (USD Million)
Table 131 Rest of Asia-Pacific: Genomics Market, by End User, 2022–2031 (USD Million)
Table 132 Latin America: Genomics Market, by Country/Region, 2022–2031 (USD Million)
Table 133 Latin America: Genomics Market, by Offering, 2022–2031 (USD Million)
Table 134 Latin America: Genomics Market, by Technology, 2022–2031 (USD Million)
Table 135 Latin America: Sequencing Market, by Type, 2022–2031 (USD Million)
Table 136 Latin America: Genomics Market, by Application, 2022–2031 (USD Million)
Table 137 Latin America: Genomics Market for Life Science Research, by Type, 2022–2031 (USD Million)
Table 138 Latin America: Genomics Market, by End User, 2022–2031 (USD Million)
Table 139 Brazil: Genomics Market, by Offering, 2022–2031 (USD Million)
Table 140 Brazil: Genomics Market, by Technology, 2022–2031 (USD Million)
Table 141 Brazil: Sequencing Market, by Type, 2022–2031 (USD Million)
Table 142 Brazil: Genomics Market, by Application, 2022–2031 (USD Million)
Table 143 Brazil: Genomics Market for Life Science Research, by Type, 2022–2031 (USD Million)
Table 144 Brazil: Genomics Market, by End User, 2022–2031 (USD Million)
Table 145 Mexico: Genomics Market, by Offering, 2022–2031 (USD Million)
Table 146 Mexico: Genomics Market, by Technology, 2022–2031 (USD Million)
Table 147 Mexico: Sequencing Market, by Type, 2022–2031 (USD Million)
Table 148 Mexico: Genomics Market, by Application, 2022–2031 (USD Million)
Table 149 Mexico: Genomics Market for Life Science Research, by Type, 2022–2031 (USD Million)
Table 150 Mexico: Genomics Market, by End User, 2022–2031 (USD Million)
Table 151 Rest of Latin America: Genomics Market, by Offering, 2022–2031 (USD Million)
Table 152 Rest of Latin America: Genomics Market, by Technology, 2022–2031 (USD Million)
Table 153 Rest of Latin America: Sequencing Market, by Type, 2022–2031 (USD Million)
Table 154 Rest of Latin America: Genomics Market, by Application, 2022–2031 (USD Million)
Table 155 Rest of Latin America: Genomics Market for Life Science Research, by Type, 2022–2031 (USD Million)
Table 156 Rest of Latin America: Genomics Market, by End User, 2022–2031 (USD Million)
Table 157 Middle East & Africa: Genomics Market, by Offering, 2022–2031 (USD Million)
Table 158 Middle East & Africa: Genomics Market, by Technology, 2022–2031 (USD Million)
Table 159 Middle East & Africa: Sequencing Market, by Type, 2022–2031 (USD Million)
Table 160 Middle East & Africa: Genomics Market, by Application, 2022–2031 (USD Million)
Table 161 Middle East & Africa: Genomics Market for Life Science Research, by Type, 2022–2031 (USD Million)
Table 162 Middle East & Africa: Genomics Market, by End User, 2022–2031 (USD Million)
Table 163 Recent Developments, by Company, 2020–2024
List of Figures
Figure 1 Research Process
Figure 2 Secondary Sources Referred for This Study
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply Side & Dem and Side)
Figure 6 Market Sizing and Growth Forecast Approach
Figure 7 Global Genomics Market, by Offering, 2024 Vs. 2031 (USD Million)
Figure 8 Global Genomics Market, by Technology, 2024 Vs. 2031 (USD Million)
Figure 9 Global Genomics Market, by Application, 2024 Vs. 2031 (USD Million)
Figure 10 Global Genomics Market, by End User, 2024 Vs. 2031 (USD Million)
Figure 11 Genomics Market, by Geography
Figure 12 Impact Analysis of Market Dynamics
Figure 13 Healthcare Expenditure as A Percentage of GDP in Major Countries, 2015 Vs. 2020
Figure 14 Global Pharmaceutical R&D Expenditure, 2012–2022 (USD Billion)
Figure 15 Estimated Number of New Cancer Cases, by Region, 2020 Vs. 2030 (in Thousand)
Figure 16 Percentage of FDA Approvals for Personalized Medicine, 2015-2021
Figure 17 USFDA Regulatory Pathways for Genomic Products
Figure 18 EU Regulatory Pathway IVDR 2017/746
Figure 19 China: Medical Device Classification and Pre-Market Requirements for IVD Devices
Figure 20 Porter's Five Forces Analysis
Figure 21 Global Genomics Market, by Offering, 2024 Vs. 2031 (USD Million)
Figure 22 Global Genomics Market, by Technology, 2024 Vs. 2031 (USD Million)
Figure 23 Global Genomics Market, by Application, 2024 Vs. 2031 (USD Million)
Figure 24 Global Pharmaceutical R&D Expenditure, 2014—2026 (USD Billion)
Figure 25 Cancer Incidence Cases, 2020 Vs. 2040
Figure 26 Global Genomics Market, by End User, 2024 Vs. 2031 (USD Million)
Figure 27 Global Pharmaceutical R&D Spending, 2012–2026 (USD Billion)
Figure 28 Global Genomics Market Assessment, by Region, 2024 Vs. 2031 (USD Million)
Figure 29 North America: Genomics Market Snapshot
Figure 30 Europe: Genomics Market Snapshot
Figure 31 Asia-Pacific: Genomics Market Snapshot
Figure 32 Latin America: Genomics Market Snapshot
Figure 33 Key Growth Strategies Adopted by Leading Players, 2020–2023
Figure 34 Genomics Market: Competitive Benchmarking, by Offering
Figure 35 Genomics Market: Competitive Benchmarking, by Geography
Figure 36 Competitive Dashboard: Genomics Market
Figure 37 Global Genomics Market Share Analysis, by Key Players
Figure 38 Thermo Fisher Scientific, Inc.: Financial Overview (2022)
Figure 39 Illumina, Inc.: Financial Overview (2022)
Figure 40 Qiagen N.V.: Financial Overview (2022)
Figure 41 Danaher Corporation: Financial Overview (2022)
Figure 42 Agilent Technologies, Inc.: Financial Overview (2023)
Figure 43 Bio-Rad Laboratories, Inc.: Financial Overview (2022)
Figure 44 Pacific Biosciences of California, Inc.: Financial Overview (2022)
Figure 45 Oxford Nanopore Technologies plc.: Financial Overview (2022)
Figure 46 Eppendorf SE: Financial Overview (2022)
Figure 47 Myriad Genetics, Inc.: Financial Overview (2022)
Figure 48 PerkinElmer, Inc.: Financial Overview (2022)
Figure 49 BGI Genomics Co.,Ltd.: Financial Overview (2022)